Exact Mass: 715.3711564

Exact Mass Matches: 715.3711564

Found 25 metabolites which its exact mass value is equals to given mass value 715.3711564, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Saquinavir-NO

N-{4-[3-(tert-butyl-C-hydroxycarbonimidoyl)-decahydroisoquinolin-2-yl]-3-(nitrooxy)-1-phenylbutan-2-yl}-2-[(quinolin-2-yl)formamido]butanediimidate

C38H49N7O7 (715.3693284000001)

Amamistatin B

C36H53N5O10 (715.3792238)

9alpha,13alpha-diacetoxy-10beta-benzyloxy-5alpha-(3-dimethylamino-3-phenyl)-propionyloxy-11(15->1)abeotaxa-4(20),11-diene-15-ol

C42H53NO9 (715.3720128)

Phe Gln Phe Phe Lys

C38H49N7O7 (715.3693284000001)

FQFFK

Phe Gln Phe Phe Lys

C38H49N7O7 (715.3693284000001)

Boc-Gln-Arg-Arg-AMC

C32H49N11O8 (715.3765394000001)

H-Gly-Arg-Gly-Asp-Ser-Pro-Lys-OH acetate salt

C28H49N11O11 (715.3612844)

GRGDSPK (EMD 56574) is a peptide incluing Arg-Gly-Asp (RGD). GRGDSPK (EMD 56574) is an competitive and reversible inhibitory peptide for inhibiting integrin-fibronectin binding. GRGDSPK is used to study the role of integrins in bone formation and resorption[1][2].

N-{4-[3-(tert-butylcarbamoyl)-octahydro-1H-isoquinolin-2-yl]-3-(nitrooxy)-1-phenylbutan-2-yl}-2-(quinolin-2-ylformamido)succinamide

C38H49N7O7 (715.3693284000001)

A peptide anion obtained from the deprotonation of the two carboxy groups, and protonation of the primary amino group of neocasomorphin. It is the major species at pH 7.3.

PS O-29:6;O3

C35H58NO12P (715.3696438)

PS P-18:1/11:4;O3

C35H58NO12P (715.3696438)

PS 16:1/13:4;O2

C35H58NO12P (715.3696438)

PS 20:1/9:4;O2

C35H58NO12P (715.3696438)

PS 20:4/9:1;O2

C35H58NO12P (715.3696438)

PS 22:2/7:3;O2

C35H58NO12P (715.3696438)

PS 29:5;O2

C35H58NO12P (715.3696438)

(2r,3s)-n-[(3r)-1-hydroxy-2-oxoazepan-3-yl]-3-{[(2s)-2-({hydroxy[2-(2-hydroxyphenyl)-5-methyl-1,3-oxazol-4-yl]methylidene}amino)-6-(n-hydroxyacetamido)hexanoyl]oxy}-2-methyldecanimidic acid

C36H53N5O10 (715.3792238)

n-(1-hydroxy-2-oxoazepan-3-yl)-3-{[2-({hydroxy[2-(2-hydroxyphenyl)-5-methyl-1,3-oxazol-4-yl]methylidene}amino)-6-(n-hydroxyacetamido)hexanoyl]oxy}-2-methyldecanimidic acid

C36H53N5O10 (715.3792238)

2-[(2-{[(1-{2-[(2-amino-9-chlorononyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl)(hydroxy)methylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino]-3-(4-hydroxyphenyl)propanoic acid

C37H54ClN5O7 (715.3711564)

(2s,3as,4ar,6s,8ar,9r,10r)-2,9-bis(acetyloxy)-6-{[(3r)-3-(dimethylamino)-3-phenylpropanoyl]oxy}-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-5-methylidene-2h,3h,4h,4ah,6h,7h,8h,9h,10h-cyclohexa[f]azulen-10-yl benzoate

(2s,3as,4ar,6s,8ar,9r,10r)-2,9-bis(acetyloxy)-6-{[(3r)-3-(dimethylamino)-3-phenylpropanoyl]oxy}-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-5-methylidene-2h,3h,4h,4ah,6h,7h,8h,9h,10h-cyclohexa[f]azulen-10-yl benzoate

C42H53NO9 (715.3720128)

2,9-bis(acetyloxy)-6-{[3-(dimethylamino)-3-phenylpropanoyl]oxy}-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-5-methylidene-2h,3h,4h,4ah,6h,7h,8h,9h,10h-cyclohexa[f]azulen-10-yl benzoate

C42H53NO9 (715.3720128)

(3s)-n-[(3s)-1-hydroxy-2-oxoazepan-3-yl]-3-{[(2r)-2-({hydroxy[2-(2-hydroxyphenyl)-5-methyl-1,3-oxazol-4-yl]methylidene}amino)-6-(n-hydroxyformamido)hexanoyl]oxy}-2,2-dimethyldecanimidic acid

C36H53N5O10 (715.3792238)

(3r)-n-[(3s)-1-hydroxy-2-oxoazepan-3-yl]-3-{[(2r)-2-({hydroxy[2-(2-hydroxyphenyl)-5-methyl-1,3-oxazol-4-yl]methylidene}amino)-6-(n-hydroxyformamido)hexanoyl]oxy}-2,2-dimethyldecanimidic acid

C36H53N5O10 (715.3792238)